GlaxoSmithKline may split up group, spin off consumer division: Report

GlaxoSmithKline Plc is considering a break-up of the group after investors pressed the company's board to spin off its consumer division, the Financial Times reported on Friday. GSK Chairman Philip Hampton has been in discussions with the group's biggest shareholders about the creation of a standalone pharma and vaccines company in the medium term, the FT reported, citing sources. The move could happen within two or three years, the report said. One of the company's top ten shareholders, whom.

This article is no longer available in our repository.

There could be multiple reasons for this.